2.73
price down icon5.86%   -0.17
after-market After Hours: 2.73
loading

Compass Therapeutics Inc Stock (CMPX) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
-
- - - -
Operating Expenses
17.04%
12.77
15.39 11.93 13.34 9.711
Depreciation and Amortization
4.35%
0.154
0.161 0.164 0.18 0.194
Operating Income/Loss
17.04%
-12.77
-15.39 -11.93 -13.34 -9.711
Income/Loss From Continuing Operations Before Tax
19.59%
-10.79
-13.41 -9.964 -11.28 -7.837
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
19.59%
-10.79
-13.41 -9.964 -11.28 -7.837
Net Income/Loss
19.59%
-10.79
-13.41 -9.964 -11.28 -7.837
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
71,799%
136.61
0.19 127.42 126.73 126.38
Basic Earnings Per Share
20.00%
-0.08
-0.10 -0.08 -0.09 -0.06
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$76.29
price down icon 6.45%
$22.96
price up icon 1.23%
$33.86
price up icon 0.65%
$19.13
price down icon 7.54%
biotechnology ONC
$245.53
price down icon 9.67%
$111.56
price down icon 1.20%
Cap:     |  Volume (24h):